Reata Pharmaceuticals Inc (RETA) insider trading
Every open-market stock purchase and sale by Reata Pharmaceuticals Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- No open-market insider trades in the last 12 months.
- Last insider buy: Manmeet Singh Soni (CFO), $420K, 4 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales).
Recent RETA insider trades
No open-market trades in the last 12 months.
Get free alerts when an insider at Reata Pharmaceuticals Inc files a new trade →